Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
Status:
Completed
Trial end date:
2016-11-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the serum levels (pharmacokinetics) of bupivacaine
in a series of patients undergoing simultaneous bilateral total knee arthroplasty with the
use of a standardized periarticular injection containing free bupivacaine and liposomal
bupivacaine.